| Primary tumor (T)* | |||
| TX: Primary tumor cannot be assessed | |||
| T0: No evidence of primary tumor | |||
| Tis: Carcinoma in situ or PanInIII | |||
| T1: Tumor limited to the pancreas and ≤2 cm in greatest diameter | |||
| T2: Tumor limited to the pancreas and >2 cm in greatest diameter | |||
| T3: Tumor extends beyond the pancreas but does not involve the celiac axis or SMA | |||
| T4: Tumor involves the celiac axis or SMA | |||
| Regional lymph nodes (N) | |||
| NX: Regional lymph nodes cannot be assessed | |||
| N0: No regional lymph node involvement | |||
| N1: Regional lymph node metastases | |||
| Distant metastases (M) | |||
| M0: No distant metastases | |||
| M1: Distant metastases | |||
|
| |||
| Stage grouping based on TNM classification | |||
| 0 | T0, Tis | N0 | N0 |
|
| |||
| I | T1 or T2 | N0 | M0 |
|
| |||
| II | T3 | N0 | M0 |
|
| |||
| T1–T3 | N1 | M0 | |
|
| |||
| III | T4 | Any N | M0 |
|
| |||
| IV | Any T | Any N | M1 |
Primary tumor was assessed by contrast-enhanced CT scan.